Systematic review of pneumococcal disease costs and productivity loss studies in Latin America and the Caribbean

Vaccine

Volumn 31, Issue SUPPL.3, 2013, Pages

  Bahia, Luciana ^a   Toscano, Cristiana M ^b   Takemoto, Maíra Libertad Soligo ^a   Araujo, Denizar Vianna ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

Cost of illness; Latin America; Pneumococcal disease; Productivity loss; Systematic review

Indexed keywords

CENTRAL AMERICA; CHILE; COLOMBIA; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DATA BASE; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HUMAN; MEDICAL SUBJECT HEADINGS; MEXICO; MORBIDITY; MORTALITY; PATHOGEN LOAD; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; PRODUCTIVITY; REPRODUCIBILITY; REVIEW; SOCIETY; SOUTH AND CENTRAL AMERICA; STANDARD; SYSTEMATIC REVIEW; URUGUAY;

CARIBBEAN REGION; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; COST-BENEFIT ANALYSIS; EFFICIENCY; HEALTH CARE COSTS; HUMANS; LATIN AMERICA; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; REPRODUCIBILITY OF RESULTS;

EID: 84879221239     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.05.030     Document Type: Review

References (27)

1. O'Brien K.L., Wolfson L.J., Watt J.P., Henkle E., Deloria-Knoll M., McCall N., et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009, 374(9693):893-902.
2. World Health Organization (WHO) Pneumococcal conjugate vaccine for childhood immunization [position paper]. Wkly Epidemiol Rec 2007, 82(12):93-104.
3. Constenla D., Gomez E., de la Hoz F., O'Loughlin R., Sinha A., Valencia J.E., et al. The burden of pneumococcal disease and cost-effectiveness of a pneumococcal vaccine in Latin America and the Caribbean: a review of the evidence and preliminary report 2007, Sabin Vaccine Institute, Washington, DC, [accessed 08.03.12]. http://www.ispch.cl/sites/default/files/document1.pdf.
4. Jauregui B., Sinha A., Clark A.D., Bolanos B.M., Reschd S., Toscano C.M., et al. Strengthening the technical capacity at country-level to make informed policy decisions on new vaccine introduction: lessons learned by PAHO's ProVac initiative. Vaccine 2010, 29(5):1099-1106.
5. Liberati A., Altman D.G., Tetzlaff J., Mulrow C., Gøtzsche P.C., Ioannidis J.P.A., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Br Med J 2009, 339:b2700.
6. Brazilian Theses Databank. Available at: [accessed 10.05.12]. http://www.capes.gov.br/servicos/banco-de-teses.
7. Index Mundi Inflation rate (consumer prices); historical data graphs per year [Internet]. Available at: [accessed 10.06.12]. http://www.indexmundi.com/g/g.aspx%3Fv=71%26c=us%26l=en.
8. World Bank PPP conversion factor [World Bank website]. Available at: [accessed 10.05.12]. http://data.worldbank.org/indicator/PA.NUS.PPP.
9. Vespa G., Constenla D.O., Pepe C., Safadi M.A., Berezin E., de Moraes J.C., et al. Estimating the cost-effectiveness of pneumococcal conjugate vaccination in Brazil. Rev Panam Salud Publica 2009, 26(6):518-528.
10. de Souza C.P.R., Ribeiro J.G.L., Moraes J.C., Berezin E., Monteiro R.D.C., Presa J. Cost-effectiveness analysis of 7-valent pneumococcal conjugate vaccine in prevention of pneumococcal disease within the SUS scenario. Braz J Health Econ 2009, 1(1):11-17.
11. Lucarevschi B.R., Escobar A.M., Grisi S. Custos hospitalares da meningite causada por Streptococcus pneumoniae na cidade de São José dos Campos, SP. Cad Saúde Pública 2012, 28(4):740-748.
12. Soarez P.C., Novaes H.M.D. Cost-effectiveness of introducing the 10-valent pneumococcal conjugate vaccine into the universal immunisation of infants in Brazil. J Epidemiol Community Health 2012, 66(3):210-217.
13. Augustovski F.A., García Martí S., Pichon-Riviere A., Debbag R. Childhood pneumococcal disease burden in Argentina. Rev Panam Salud Publica 2009, 25(5):423-430.
14. Giglio N.D., Cane A.D., Micone P., Gentile A. Cost-effectiveness of the CRM-based 7-valent pneumococcal conjugated vaccine (PCV7) in Argentina. Vaccine 2010, 28(11):2302-2310.
15. Urueña A., Pippo T., Betelu M.S., Virgilio F., Giglio N., Gentile A., et al. Cost-effectiveness analysis of the 10- and 13-valent pneumococcal conjugate vaccines in Argentina. Vaccine 2011, 29:4963-4972.
16. Guzmán N.A., de la Hoz-Restrepo F., Higuera A.B., Pastor D., Di Fabio J.L. Costos económicos de las neumonías en niños menores de 2 años de edad, en Colombia. Rev Panam Salud Publica 2005, 17(3):178-183.
17. Guzmán N.A., de la Hoz F. Cost effectiveness of heptavalent pneumococcal conjugate vaccine in populations of high risk in Colombia. Colomb Med 2010, 41:315-322.
18. Talbird S.E., Taylor T.N., Caporale J., Ismaila A.S., Gomez J. Residual economic burden of Streptococcus pneumoniae- and nontypeable Haemophilus influenzae-associated disease following vaccination with PCV-7: a multicountry analysis. Vaccine 2010, 28(Suppl. 6):G14-G22.
19. Muciño-Ortega E., Mould-Quevedo J.F., Farkouh R. Economic evaluation of an infant immunization program in Mexico, based on 13-valent pneumococcal conjugated vaccines. Value Health 2011, 14(5 Suppl. 1):S65-S70.
20. Larraz G.G., Ortiz H.T., Mourine N.S., Giglio N., Cané A., García M.C.P., et al. Costo-efectividad de la vacunación universal antineumocócica en Uruguay. Rev Panam Salud Publica 2010, 28(2):92-99.
21. Lagos R., Muñoz A., Espinoza A., Dowes A., Ruttimann R., Colindres R., et al. Costos médicos directos de enfermedades neumocócicas invasoras y neumonías con diagnóstico radiológico en niños chilenos. Rev Panam Salud Publica 2009, 26(2):101-111.
22. Constenla D. Evaluating the costs of pneumococcal disease in selected Latin American countries. Rev Panam Salud Publica 2007, 22(4):268-278.
23. Constenla D.O. Economic impact of pneumococcal conjugate vaccination in Brazil, Chile, and Uruguay. Rev Panam Salud Publica 2008, 24(2):101-112.
24. Sinha A., Constenla D., Valencia J.E., O'Loughlin R., Gomez E., de la Hoz F., et al. Cost-effectiveness of pneumococcal conjugate vaccination in Latin America and the Caribbean: a regional analysis. Rev Panam Salud Publica 2008, 24(5):304-313.
25. Drummond M.F., Sculpher M.J., Torrance G.W., O'brien B.J., Stoddart G.L. Methods for the economic evaluation of health care programmes 2005, Oxford University press, Oxford. 3rd ed.
26. World Bank World Bank Data. [Website]. Available at: [accessed 12.01.13]. http://wdronline.worldbank.org/worldbank/a/incomelevel.
27. World Health Organization. WHO-CHOICE. Available at: [accessed 10.05.12]. http://www.who.int/choice/en/.